Literature DB >> 5363298

[Treatment of amyloidoses].

H P Missmahl.   

Abstract

Mesh：

Substances：

Year:  1969        PMID： 5363298     DOI： 10.1055/s-0028-1110507

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  6 in total

1.  [Hans-Peter Missmahl (16.5.1920-28.1.2008): pioneer in clinical and pathohistological amyloid research].

Authors:  W Saeger
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

2.  Effect of imuran on the course of experimental amyloidosis.

Authors:  R G Arustamova; V V Serov; N A Mukhin; T N Drozd; T A Berezina
Journal:  Bull Exp Biol Med       Date:  1974-08       Impact factor: 0.804

3.  [Probability of amyloidosis and primary disease].

Authors:  K Lüders
Journal:  Klin Wochenschr       Date:  1971-05

4.  [Primary amyloidosis with nephrotic syndrome: 5 year follow-up under polychemotherapy. A case report (author's transl)].

Authors:  B Emmerich; A Kircher; U Fink; L Schmid; J Rastetter
Journal:  Klin Wochenschr       Date:  1980-11-03

Review 5.  [Endogenous storage diseases of the lung. Attempt at classification clinical diagnosis and problems].

Authors:  F J Bassermann
Journal:  Pneumonologie       Date:  1971

6.  [The influence of dyes with special affinity to amyloid on the resorption of casein-induced amyloidosis in mice (author's transl)].

Authors:  P Schmitz-Moormann
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.